Klotho NeurosciencesNASDAQ: KLTO

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$5.59 M
-95%vs. 3y high
13%vs. sector
-vs. 3y high
-vs. sector
-100%vs. 3y high
10%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Wed, 30 Oct 2024 13:30:00 GMT
$0.51$0.00(0.00%)

Dividend

No data over the past 3 years
$0.00-$451.64 K

Analysts recommendations

Institutional Ownership

Included in screeners

No data

KLTO Latest News

Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
prismmediawire.com23 October 2024 Sentiment: POSITIVE

Discoverer of Klotho gene further strengths KLTO Scientific Advisory Board New York, NY, October 23, 2024 – PRISM MediaWire – Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related diseases, is proud to announce the appointment of Dr.

Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
globenewswire.com23 October 2024 Sentiment: POSITIVE

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related diseases, is proud to announce the appointment of Dr. Makoto Kuro-o to its Scientific Advisory Board. Dr. Kuro-o, a distinguished Japanese physician-scientist, is widely recognized as the pioneer behind the discovery of the Klotho gene, often referred to as the "anti-aging gene.

What type of business is Klotho Neurosciences?

Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

What sector is Klotho Neurosciences in?

Klotho Neurosciences is in the Healthcare sector

What industry is Klotho Neurosciences in?

Klotho Neurosciences is in the Biotechnology industry

What country is Klotho Neurosciences from?

Klotho Neurosciences is headquartered in United States

What is Klotho Neurosciences website?

https://www.klothoneuro.com

Is Klotho Neurosciences in the S&P 500?

No, Klotho Neurosciences is not included in the S&P 500 index

Is Klotho Neurosciences in the NASDAQ 100?

No, Klotho Neurosciences is not included in the NASDAQ 100 index

Is Klotho Neurosciences in the Dow Jones?

No, Klotho Neurosciences is not included in the Dow Jones index

When was Klotho Neurosciences the previous earnings report?

No data

When does Klotho Neurosciences earnings report?

Next earnings report date is not announced yet